Nanoparticle encapsulated lipopeptide conjugate of antitubercular drug isoniazid: in vitro intracellular activity and in vivo efficacy in a Guinea pig model of tuberculosis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Bioconjugate chemistry

• Publication date

  2014-11-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/bc500476xPMID 25394206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.

  2013cited by this paper
• Potent Rifamycin-Sparing Regimen Cures Guinea Pig Tuberculosis as Rapidly as the Standard Regimen

  2013cited by this paper
• Mycobacterium tuberculosis: success through dormancy.

  2012cited by this paper
• Depolymerized chitosans functionalized with bPEI as carriers of nucleic acids and tuftsin-tethered conjugate for macrophage targeting.

  2012cited by this paper
• Isoniazid: the magic molecule

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Membrane affinity of antituberculotic drug conjugate using lipid monolayer containing mycolic acid

  2012cited by this paper
• Enhanced cellular uptake of a new, in silico identified antitubercular candidate by peptide conjugation.

  2012cited by this paper
• Nanomedicine and experimental tuberculosis: facts, flaws, and future.

  2011cited by this paper
• Nanoencapsulation of Antitubercular Drug Isoniazid and Its Lipopeptide Conjugate

  2011cited by this paper
• The challenge of new drug discovery for tuberculosis

  2011cited by this paper
• New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

  2010cited by this paper
• Comparison of the ‘Denver regimen’ against acute tuberculosis in the mouse and guinea pig

  2010cited by this paper
• Antibiotics for Emerging Pathogens

  2009cited by this paper
• Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.

  2009cited by this paper
• Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.

  2009cited by this paper
• Peptide conjugates of therapeutically used antitubercular isoniazid—design, synthesis and antimycobacterial effect

  2009cited by this paper
• Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.

  2009cited by this paper
• Design, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexate.

  2008cited by this paper
• What animal models teach humans about tuberculosis.

  2008cited by this paper
• Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.

  2006cited by this paper
• Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.

  2005cited by this paper
• The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

  2005cited by this paper
• In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: part 14.

  2005cited by this paper
• PLGA nanoparticles in drug delivery: the state of the art.

  2004cited by this paper
• Isoniazid Pharmacokinetics-Pharmacodynamics in an Aerosol Infection Model of Tuberculosis

  2004cited by this paper
• Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin.

  2004cited by this paper
• Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin‐like sequence

  2004cited by this paper
• In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones.

  2004cited by this paper
• Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.

  2004cited by this paper
• Chemotherapeutic Potential of Orally Administered Poly(Lactide-Co-Glycolide) Microparticles Containing Isoniazid, Rifampin, and Pyrazinamide against Experimental Tuberculosis

  2003cited by this paper
• Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.

  2003cited by this paper
• Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.

  2003cited by this paper
• Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

  2003cited by this paper
• Superior Chemotherapeutic Efficacy of Amphotericin B in Tuftsin-bearing Liposomes against Leishmania Donovani Infection in Hamsters

  2002cited by this paper
• Current medical treatment for tuberculosis

  2002cited by this paper
• In Vitro Antimycobacterial Activities of 2′-Monosubstituted Isonicotinohydrazides and Their Cyanoborane Adducts

  2002cited by this paper
• Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

  2002cited by this paper
• In Vitro Model of Hypoxically Induced Nonreplicating Persistence of Mycobacterium tuberculosis.

  2001cited by this paper
• Comparative Antimicrobial Activities of the Newly Synthesized Quinolone WQ-3034, Levofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis andMycobacterium avium Complex

  2000cited by this paper
• Tuftsin: on the 30-year anniversary of Victor Najjar's discovery.

  1999cited by this paper
• A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides

  1999cited by this paper
• Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI.

  1998cited by this paper
• Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction

  1997cited by this paper
• Biodegradation and biocompatibility of PLA and PLGA microspheres.

  1997cited by this paper
• Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies

  1996cited by this paper
• Guinea Pig Model of Tuberculosis

  1994cited by this paper
• Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice

  1994cited by this paper
• The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

  1992cited by this paper
• Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine

  1990cited by this paper
• Drug targeting in Leishmania donovani infections using tuftsin‐bearing liposomes as drug vehicles

  1989cited by this paper
• Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes

  1988cited by this paper
• Receptor‐mediated Internalization of Tuftsin a

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Tuftsin receptors.

  1983cited by this paper
• Tuftsin‐macrophage interaction: Specific binding and augmentation of phagocytosis

  1979cited by this paper
• STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS.

  1963cited by this paper
• WHO CO-OPERATIVE STUDIES ON A SIMPLE CULTURE TECHNIQUE FOR THE ISOLATION OF MYCOBACTERIA. 2. COMPARISON OF THE EFFICACY OF LYOPHILIZED LIQUID MEDIUM WITH THAT OF LOEWENSTEIN-JENSEN (L-J) MEDIUM.

  1963cited by this paper
• WHO CO-OPERATIVE STUDIES ON A SIMPLE CULTURE TECHNIQUE FOR THE ISOLATION OF MYCOBACTERIA. 1. PREPARATION, LYOPHILIZATION AND RECONSTITUTION OF A SIMPLE SEMI-SYNTHETIC CONCENTRATED LIQUID MEDIUM; CULTURE TECHNIQUE; GROWTH PATTERN OF DIFFERENT MYCOBACTERIA.

  1963cited by this paper

• Advancement of functional peptides: Promising candidates for antituberculosis therapeutics

  2026cites this paper
• Gelatin Nanoparticles as Carrier for Effective Antituberculosis Drug Delivery in Combination Therapy

  2024cites this paper
• An Overview of Polymeric Nanoplatforms to Deliver Veterinary Antimicrobials

  2024cites this paper
• Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy

  2023cites this paper
• Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for Mycobacterium tuberculosis Infection—A Review

  2023cites this paper
• Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides.

  2022cites this paper
• Macrophage-Targeted Chemotherapy for Tuberculosis

  2022cites this paper
• Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages

  2022cites this paper
• Evaluating the antibacterial activity of muramyl dipeptide derivatives, retro-tuftsin derivatives, and anthraquinone oligopeptides against a range of pathogenic bacteria.

  2021cites this paper
• One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics

  2021cites this paper
• Novel Assay Platform to Evaluate Intracellular Killing of Mycobacterium tuberculosis: In Vitro and In Vivo Validation

  2021cites this paper
• Dual pH-Responsive Macrophage-Targeted Isoniazid Glycoparticles for Intracellular Tuberculosis Therapy.

  2021cites this paper
• Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis

  2020cites this paper
• Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance

  2020cites this paper
• Engineering materials

  2020cites this paper
• Integrative Nanomedicine for New Therapies

  2020cites this paper
• Nanoparticle drug conjugates treating microbial and viral infections: A review

  2020cites this paper
• Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the treatment of infectious diseases and tumors.

  2020cites this paper
• Polymer-based nanoparticles as delivery systems for treatment and vaccination of tuberculosis

  2020cites this paper
• Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery

  2020cites this paper
• Amidated pleurocidin peptide encapsulated in biodegradable poly(lactide-co-glycolide) microparticles sustains its antibacterial activity against Photobacterium damselae subsp. piscicida in cobia

  2019cites this paper
• Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.

  2019cites this paper
• Nanomedicine progress in prevention, detection, and treatment of tuberculosis

  2019cites this paper
• A method for the prediction of drug content of poly(lactic-co-glycolic)acid drug carrier nanoparticles obtained by nanoprecipitation

  2019cites this paper
• Chemical structure and in vitro cellular uptake of luminescent carbon quantum dots prepared by solvothermal and microwave assisted techniques.

  2019cites this paper
• Interaction of antitubercular drug candidates with α1-acid glycoprotein produced in pulmonary granulomas.

  2019cites this paper
• New potential drug leads against MDR-MTB: A short review.

  2019cites this paper
• Enhanced Delivery of 4-Thioureidoiminomethylpyridinium Perchlorate in Tuberculosis Models with IgG Functionalized Poly(Lactic Acid)-Based Particles

  2018cites this paper
• Biodistribution of Tc-99m Labeled Isoniazid Solid Lipid Nanoparticles in Wistar Rats

  2018cites this paper
• Delivery of antituberculosis drugs to Mycobacterium tuberculosis H37Rv infected macrophages via polylactide-co-glycolide (PLGA) nanoparticles

  2018cites this paper
• Membrane affinity and fluorescent labelling: comparative study of monolayer interaction, cellular uptake and cytotoxicity profile of carboxyfluorescein-conjugated cationic peptides

  2018cites this paper
• Selective detection of Co2+ by fluorescent nano probe: Diagnostic approach for analysis of environmental samples and biological activities.

  2018cites this paper
• Clathrin-Independent Killing of Intracellular Mycobacteria and Biofilm Disruptions Using Synthetic Antimicrobial Polymers.

  2017cites this paper
• Nanoantimicrobials: Activity, Benefits, and Weaknesses

  2017cites this paper
• Synthesis of acyl-hydrazone from usnic acid and isoniazid and its anti-Mycobacterium tuberculosis activity

  2017cites this paper
• Amphiphilic polymer layer – Model cell membrane interaction studied by QCM and AFM

  2017cites this paper
• Tuftsin - Properties and Analogs.

  2017cites this paper
• Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application

  2017cites this paper
• Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology - From Drug Discovery to Nanocarrier Design and Development.

  2017cites this paper
• In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.

  2017cites this paper
• Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.

  2017cites this paper
• In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles

  2016cites this paper
• The formulation of nanomedicines for treating tuberculosis.

  2016cites this paper
• Development and Optimization of Dual Drugs (Isoniazid and Moxiflox-acin) Loaded Functional PLGA Nanoparticles for the Synergistic Treatment of Tuberculosis.

  2016cites this paper
• A poly(ether-ester) copolymer for the preparation of nanocarriers with improved degradation and drug delivery kinetics.

  2016cites this paper
• Comparative analysis of new peptide conjugates of antitubercular drug candidates-Model membrane and in vitro studies.

  2016cites this paper
• pH-Triggered Controllable Release of Silver-Indole-3 Acetic Acid Complexes from Mesoporous Silica Nanoparticles (IBN-4) for Effectively Killing Malignant Bacteria.

  2015cites this paper
• Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models.

  2015cites this paper